IL-1 inhibition with anakinra in a patient with refractory gout.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases ·Vol. 15 ·No. 7 ·2009-10-00 ·Pages 366

Singh D, Huston KK

Abstract

暂无摘要

MeSH Terms

Antirheumatic Agents/administration & dosage,adverse effects,therapeutic use Gout/drug therapy Humans Injections, Subcutaneous Interleukin 1 Receptor Antagonist Protein/administration & dosage,adverse effects,therapeutic use Interleukin-1/antagonists & inhibitors Male Middle Aged Treatment Outcome

Chemicals

Antirheumatic Agents Interleukin 1 Receptor Antagonist Protein Interleukin-1

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Singh Dushyant

Department of Internal Medicine, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.

Huston K Kwasind

Article Info

Journal

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Abbr.

J Clin Rheumatol

ISSN

1536-7355

DOI

10.1097/RHU.0b013e3181be2423

Published

2009-10-00

Pages

366

Language

English

Region

United States

NLM ID

9518034

Subset

External Links

PubMed source DOI: 10.1097/RHU.0b013e3181be2423 View journal details

Analysis Services

IL-1 inhibition with anakinra in a patient with refractory gout.

Contact

WeChat Official Account